82 press releases were issued in the past 24 hours, and 184,871 press releases were issued in the past 365 days.

Increasing demand for peripheral insertion of central catheters in developing countries

New York City, New York, USA, November 17, 2021/EINPresswire.com/-According to a new report from Reports and Data, by 2028, the global peripheral inserted central catheter market is expected to reach USD 1,278.3 million. A peripherally inserted central catheter (PICC or PIC line), also called a percutaneous indwelling central catheter, is a type of venous access. It can be used for a long period of time, such as prolonging antibiotic treatment, long-term chemotherapy regimens, and substance administration. The PICC is inserted into the arm through a peripheral vein (such as the expensive vein, brachial vein, or cephalic vein), and then advanced to the proximal end of the heart through the larger and larger veins until it reaches the junction of the vena cava or the distal superior vena cava. It is usually inserted by physician assistants, physicians, specially trained registered nurse respiratory therapists, radiology assistants, and radiographers, using chest radiographs, fluoroscopy, and ultrasound to confirm its insertion and ensure placement. The insertion process is a sterile process; however, it does not require an operating room. When performing home care, it is necessary to maintain a proper sterile area throughout the process. Supporting market factors such as rising rates of chronic diseases, favorable reimbursement policies, and increased spending in the healthcare sector are driving market growth. From a regional perspective, Europe can be seen to occupy a prominent market share. The market share occupied by the region is attributed to the expansion of the healthcare sector, the increase in the elderly population and the high incidence of chronic diseases.

Get report sample@ https://www.reportsanddata.com/sample-enquiry-form/2441

The main products of the global peripheral inserting central catheter market report:

• In-depth understanding of the external central catheter market structure • Key details about the regional segmentation of the external central catheter market • Analyze key market trends of current and emerging trends • Broad overview of major manufacturers and well-known players in the industry • Market segmentation And comprehensive research on recent developments

The continuous efforts of major players to develop advanced therapies and drugs, the rapid adoption of advanced technologies such as artificial intelligence, additive manufacturing, advertising blockchain technology, and the increasing attention to precision medicine have led to rapid changes in the pharmaceutical and healthcare industries. The legalization and acceptance of medical marijuana, the growing focus on connected devices in the healthcare sector, and the popularity beyond pills have further revolutionized the healthcare industry. The emergence of the COVID-19 pandemic has played a vital role in the advancement of the healthcare industry, and its focus has quickly shifted to preventive healthcare, raising awareness of health and wellness, the development of telemedicine and teleconsultation, and advanced technology Rapid adoption to meet the growing patient population.

Apply for report discount @ https://www.reportsanddata.com/discount-enquiry-form/2441

The report provides a comprehensive overview of the competitive landscape of the market to provide key insights about the major companies operating in the market. This section discusses in detail the initiatives and innovations taken by major players to gain a foothold in the market. It also provides insights on mergers and acquisitions, joint ventures, cooperation, partnerships, and agreements to better understand the market.

Major companies in the market include:

R. Bard Inc., AngioDynamics, Inc., B. Braun Melsungen AG, Teleflex Incorporated, Vygon SA, Medtronic plc, Becton, Dickinson and Company, Cook Medical, Inc., Medical Component Inc., and Argon Medical Devices, Inc.

The further main findings of the report indicate

• The market share of the external central catheter market in 2018 was US$748.4 million and is expected to grow at a rate of 5.30% during the forecast period.

• In terms of product types, the Power Injection Peripheral Insertion Central Catheter Division generated higher revenue of US$595 million in 2018, with a compound annual growth rate of 6.1% during the forecast period. The increase in hospital accidents and emergencies and the applicability of these catheters in the ICU, where it can be used for hemodynamic monitoring, a multi-purpose centerline for any infusion, and high-pressure injection of contrast media during radiological examinations have resulted in high demand and The revenue generated by this segment.

• In terms of application, the chemotherapy segment is expected to have the fastest growth rate during the forecast period, at 6.9%, and is expected to reach 19.0% by 2027. The rising incidence of cancer and the related increase in demand for chemotherapy have led to the application of PICC in this market segment to contribute to the growth rate of this market segment.

• In terms of end users, the hospital sector had the largest market share in 2018 at 57.0%, with a compound annual growth rate of 5.7% during the forecast period. The market share held by the hospital segment is attributed to the large number of operations performed in the hospital, which leads to a high demand for these catheters by the end user. In addition, the continuous development of healthcare infrastructure in developing countries and the increase in hospitalization due to chronic diseases also help to increase the market share of this market segment.

• As far as the region is concerned, the Asia-Pacific region is expected to witness the fastest growth rate of 9.0% during the forecast period, and is expected to occupy 0% of the market share by 2027. The growth rate witnessed by the region is the result of the development of medical infrastructure. The incidence of chronic diseases in the region is increasing.

For the purpose of this report, the report and data segment the global peripheral insert central catheter market based on product type, design type, application, end user, and region:

Product type outlook (revenue, millions of dollars; 2018-2028)

• Traditional peripheral insertion of the central catheter • Energy injection of the peripheral insertion of the central catheter

Design type outlook (revenue, millions of dollars; 2018-2028)

• Multi-chamber • Double-chamber • Single-chamber

Application Outlook (Revenue, USD million; 2018-2028)

• Intravenous fluids • Chemotherapy • Blood transfusions • Other drugs

End user outlook (revenue, millions of dollars; 2018-2028)

• Hospital • Nursing Facility • Outpatient Surgery Center • Home Care

To learn more about the report @ https://www.reportsanddata.com/report-detail/peripherally-inserted-central-catheters-market

This part covers a comprehensive analysis of the production and consumption ratios of key regions, import and export analysis, supply and demand dynamics, regional trends and demand, and the presence of prominent players in each region. The regional analysis section also provides country/regional analysis to provide a panoramic view of the market and help investors, customers, stakeholders and companies better understand the opportunities and growth scope of the external central catheter market.

• North America (United States, Canada, Mexico) • Europe (UK, Italy, Germany, France, rest of Europe) • Asia Pacific (India, Japan, China, South Korea, Australia, other regions of Asia Pacific) • Latin America (Chile, Brazil) , Argentina, other regions in Latin America) • Middle East and Africa (Saudi Arabia, UAE, South Africa, other MEA regions)

Request customized report@ https://www.reportsanddata.com/request-customization-form/2441

Thank you for reading our report. For more detailed information about reports and custom features, please contact us. Our team will ensure that the report is tailored to your requirements.

Lung in vitro model market@ https://www.biospace.com/article/lung-in-vitro-market-size-to-reach-usd-976-9-million-in-2028-says-reports-and-data /

Organ Chip Market@ https://www.biospace.com/article/organs-on-chips-market-size-to-value-at-usd-294-75-million-in-2028-says-reports -and- data/

Rabies Diagnosis Market@ https://www.biospace.com/article/rabies-diagnostics-market-size-to-reach-usd-2-38-billion-in-2028-noted-reports-and-data/

Reports and Data is a market research and consulting company that provides joint research reports, customized research reports and consulting services. Our solutions are fully focused on your purpose, that is, positioning, positioning and analyzing changes in consumer behavior across demographics and industries, and helping customers make more informed business decisions. We provide market intelligence research to ensure relevant and fact-based research across multiple industries, including healthcare, technology, chemicals, power, and energy. We constantly update our research products to ensure that our customers understand the latest trends that exist in the market. Reports and Data has a strong base of experienced analysts from different professional fields.

Tushar Rajput reports and data +18008193052 ext. Email us here and visit us on social media: Facebook Twitter LinkedIn

EIN Presswire's top priority is source transparency. We do not allow non-transparent customers, and our editors will try to carefully eliminate false and misleading content. As a user, if you see something we missed, please make sure to let us pay attention. Your help is welcome. EIN Presswire, or Everyone's Internet News Presswireâ„¢, attempts to define some reasonable boundaries in today's world. Please refer to our editorial guide for more information.

© 1995-2021 IPD Group, Inc. dba EIN Presswire All rights reserved.